Certified as a comprehensive stroke center by the Joint Commission, our research activities range from multidisciplinary laboratory studies to understand stroke and its effects on the body, as well as a variety of multicenter clinical trials to better treat and prevent stroke in patients. Read more.
This multidisciplinary group investigates the genetic factors and molecular mechanisms that underlie the brain’s response to acute injury and chronic degeneration over time. Read more.
DREAMS is a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune disease (AI). Read more.
The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development. Read more.